Could a plant-based supplement calm chemo-related diarrhea?
NCT ID NCT07460596
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tested a concentrated plant dietary supplement (made from foods like taro, rice, and carrots) in 30 people with gastrointestinal cancers who had diarrhea from chemotherapy. Participants received the supplement alongside standard anti-diarrheal treatment. The goal was to see if it could help stop diarrhea faster. The study was small and had no placebo group, so results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Concentrated Phytodietary Compound (a dietary supplement made from plant foods like taro, rice, and carrots)
- What this could lead to
- If it works, this could offer a natural, food-based option to help manage chemotherapy-induced diarrhea, improving comfort during cancer treatment.
- What could go wrong
- This is a small, early-phase study with only 30 participants and no comparison group, so results may not be reliable or apply to everyone. The supplement is not a treatment for cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON AND RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Dr., China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Which rectal cancer surgery preserves quality of life better? a study investigates
- Can a new drug combo shrink Hard-to-Treat tumors?
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- Can an immunotherapy combo shrink stomach tumors before surgery?